Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome

Annals of Neurology

Volumn 45, Issue 2, 1999, Pages 168-173

  Ho, T W ^a,g   Willison, H J ^c   Nachamkin, I ^d   Li, C Y ^f   Veitch, J ^c   Ung, H ^d   Wang, G R ^f   Liu, R C ^f   Cornblath, D R ^a   Asbury, A K ^e   Griffin, J W ^a   McKhann, G M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d Laboratory Medicine   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Second Teaching Hospital   (China)

^g Pathology 509 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; IMMUNOGLOBULIN G;

ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER; CHINESE; CONTROLLED STUDY; DEMYELINATING DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MOTOR NEURON DISEASE; NERVE FIBER MEMBRANE; PATHOGENESIS; POLYNEUROPATHY; PRIORITY JOURNAL; RANVIER NODE; SCHWANN CELL;

ADOLESCENT; ADULT; ANTIBODIES; CHILD; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; POLYRADICULONEUROPATHY;

EID: 0033004906     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6     Document Type: Article

References (41)

1. Haymaker W, Kernohan JW. The Landry-Guillain-Barré syndrome: a clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine 1949;28:59-141
2. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969;48:173-215
3. Prineas JW. Acute idiopathic polyneuritis. An electron microscope study. Lab Invest 1972;26:133-147
4. Prineas JW. Pathology of the Guillain-Barré syndrome. Ann Neurol 1981;9(Suppl):S6-S19
5. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
6. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342
7. McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991;338:593-397
8. Sobue G, Li M, Terao S, et al. Axonal pathology in Japanese Guillain-Barré syndrome: a study of 15 autopsied cases. Neurology 1997;48:1694-1700
9. Ramos-Alvarez M, Bessudo L, Sabin A. Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy: acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome. JAMA 1969;207:1481-1492
10. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595
11. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135
12. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
13. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991;34: 43-51
14. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379
15. Gregson NA, Koblar S, Hughes RA. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-117
16. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816
17. Aspinall GO, Fujimoto S, McDonald AG, et al. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun 1994;62:2122-2125
18. Aspinall GO, McDonald AG, Pang H, et al. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 1994;33:241-249
19. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Infect Immun 1994;62:2101-2103
20. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775
21. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644
22. Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-635
23. Yuki N, Sato S, Tsuji S, et al. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 1993;43:414-417
24. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56:204-206
25. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller-Fisher syndrome. Ann Neurol 1992;31:677-679
26. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902
27. Kornberg AJ, Pestronk A, Bieser K, et al. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol 1994;35: 234-237
28. Visser LH, Van der Meche FG, Van Doorn PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré study group. Brain 1995; 118:841-847
29. Cornblath DR, Kuncl RW, Mellits ED, et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 1992;15:1111-1115
30. Willison HJ, Chancellor AM, Paterson G, et al. Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. J Neurol Sci 1993;114:209-215
31. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-953
32. Lugaresi A, Ragno M, Torrieri F, et al. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J Neurol Sci 1997;147:193-200
33. Yuki N, Yoshino H, Sato S, et al. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 1992;15:899-903
34. Yuki N, Yamada M, Sato S, et al. Association of IgG antiGD1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 1993;16:642-647
35. Bollensen E, Schipper HI, Steck AJ. Motor neuropathy with activity of monoclonal IgM antibody to GD1a ganglioside. J Neurol 1989;236:353-355
36. Carpo M, Nobile-Orazio E, Meucci N, et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol 1996;39:539-543
37. Svennerholm L, Fredman P. Antibody detection in Guillain-Barré syndrome. Ann Neurol 1990;27(Suppl):S36-S40
38. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol 1993;33:243-247
39. Yuki N, Takahashi M, Tagawa Y, et al. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Ann Neurol 1997;42:28-33
40. Sheikh KA, Nachamkin I, Ho TW, et al. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology 1998;51:371-378
41. Jacobs BC, van Doorn PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-187